List of Excipients in API tadalafil
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tadalafil
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Eli Lilly and Company | CIALIS | tadalafil | 0002-4465 | CELLULOSE, MICROCRYSTALLINE | |
| Eli Lilly and Company | CIALIS | tadalafil | 0002-4465 | CROSCARMELLOSE SODIUM | |
| Eli Lilly and Company | CIALIS | tadalafil | 0002-4465 | FERRIC OXIDE RED | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing tadalafil
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 | CELLULOSE, MICROCRYSTALLINE |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 | CROSCARMELLOSE SODIUM |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 | FERRIC OXIDE YELLOW |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for tadalafil
Excipient focus: ACACIA
tadalafil drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | tadalafil | 70954-433 |
| ANI Pharmaceuticals Inc | tadalafil | 70954-627 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
tadalafil drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | tadalafil | 27241-111 |
| Medsource Pharmaceuticals | tadalafil | 45865-218 |
| A-S Medication Solutions | tadalafil | 50090-5344 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
tadalafil drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| DrReddys Laboratories Inc | tadalafil | 43598-576 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARMINIC ACID
tadalafil drug variants containing CARMINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| GLENMARK PHARMACEUTICALS INC USA | tadalafil | 68462-779 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing CARMINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
tadalafil drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | tadalafil | 0480-2309 |
| Teva Pharmaceuticals Inc | tadalafil | 0480-9277 |
| Burel Pharmaceuticals LLC | tadalafil | 35573-409 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77891
tadalafil drug variants containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | tadalafil | 50090-7390 |
| A-S Medication Solutions | tadalafil | 50090-7391 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
tadalafil drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE
tadalafil drug variants containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | tadalafil | 31722-643 |
| Camber Pharmaceuticals Inc | tadalafil | 31722-647 |
| NuCare PharmaceuticalsInc | tadalafil | 68071-5092 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
tadalafil drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | tadalafil | 35573-409 |
| Burel Pharmaceuticals LLC | tadalafil | 35573-460 |
| PD-Rx Pharmaceuticals Inc | tadalafil | 43063-969 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
tadalafil drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | tadalafil | 16714-074 |
| CMP Pharma Inc | tadalafil | 46287-045 |
| Sun Pharmaceutical Industries Inc | tadalafil | 47335-009 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
tadalafil drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | tadalafil | 16714-074 |
| Sun Pharmaceutical Industries Inc | tadalafil | 47335-009 |
| A-S Medication Solutions | tadalafil | 50090-7390 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
tadalafil drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
tadalafil drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | tadalafil | 70954-627 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
tadalafil drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | tadalafil | 70954-433 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
tadalafil drug variants containing FD&C BLUE NO. 2
tadalafil drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5
tadalafil drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | tadalafil | 27241-111 |
| Medsource Pharmaceuticals | tadalafil | 45865-218 |
| A-S Medication Solutions | tadalafil | 50090-5344 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
tadalafil drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| GLENMARK PHARMACEUTICALS INC USA | tadalafil | 68462-779 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
tadalafil drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Teva Pharmaceuticals Inc | tadalafil | 0480-2309 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
tadalafil drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | tadalafil | 0480-9277 |
| Ajanta Pharma USA Inc | tadalafil | 27241-123 |
| Camber Pharmaceuticals Inc | tadalafil | 31722-643 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
tadalafil drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | tadalafil | 43547-047 |
| Solco Healthcare US LLC | tadalafil | 43547-990 |
| A-S Medication Solutions | tadalafil | 50090-7152 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: FRUCTOSE
tadalafil drug variants containing FRUCTOSE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | tadalafil | 70954-433 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing FRUCTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
tadalafil drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
tadalafil drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6976 |
| Torrent Pharmaceuticals Limited | tadalafil | 13668-565 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
tadalafil drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | tadalafil | 72789-407 |
| PD-Rx Pharmaceuticals Inc | tadalafil | 72789-408 |
| NIVAGEN PHARMACEUTICALS INC | tadalafil | 75834-247 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL METHYLCELLULOSE
tadalafil drug variants containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | tadalafil | 50090-7390 |
| A-S Medication Solutions | tadalafil | 50090-7391 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
tadalafil drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6976 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
tadalafil drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | tadalafil | 0480-2309 |
| Teva Pharmaceuticals Inc | tadalafil | 0480-9277 |
| Torrent Pharmaceuticals Limited | tadalafil | 13668-565 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
tadalafil drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | tadalafil | 29300-286 |
| Macleods Pharmaceuticals Limited | tadalafil | 33342-265 |
| Macleods Pharmaceuticals Limited | tadalafil | 33342-278 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
tadalafil drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | tadalafil | 43598-576 |
| DrReddys Laboratories Inc | tadalafil | 43598-578 |
| CMP Pharma Inc | tadalafil | 46287-045 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
tadalafil drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | tadalafil | 43547-047 |
| Solco Healthcare US LLC | tadalafil | 43547-990 |
| A-S Medication Solutions | tadalafil | 50090-7152 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
tadalafil drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | tadalafil | 27241-111 |
| Medsource Pharmaceuticals | tadalafil | 45865-218 |
| A-S Medication Solutions | tadalafil | 50090-5344 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM
tadalafil drug variants containing MAGNESIUM
| Company | Ingredient | NDC |
|---|---|---|
| GLENMARK PHARMACEUTICALS INC USA | tadalafil | 68462-779 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing MAGNESIUM
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
tadalafil drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Macleods Pharmaceuticals Limited | tadalafil | 33342-265 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
tadalafil drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | tadalafil | 70954-433 |
| ANI Pharmaceuticals Inc | tadalafil | 70954-627 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
tadalafil drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | tadalafil | 35573-409 |
| PD-Rx Pharmaceuticals Inc | tadalafil | 43063-969 |
| A-S Medication Solutions | tadalafil | 50090-4276 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
tadalafil drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| NorthStar RxLLC | tadalafil | 16714-074 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
tadalafil drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6976 |
| NorthStar RxLLC | tadalafil | 16714-074 |
| Sun Pharmaceutical Industries Inc | tadalafil | 47335-009 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
tadalafil drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Avkare | tadalafil | 42291-786 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
tadalafil drug variants containing POLYETHYLENE GLYCOL 4000
tadalafil drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
tadalafil drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | tadalafil | 46708-177 |
| Alembic Pharmaceuticals Inc | tadalafil | 62332-177 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL
tadalafil drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | tadalafil | 31722-643 |
| Camber Pharmaceuticals Inc | tadalafil | 31722-647 |
| Burel Pharmaceuticals LLC | tadalafil | 35573-409 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
tadalafil drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
tadalafil drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6976 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
tadalafil drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| Macleods Pharmaceuticals Limited | tadalafil | 33342-265 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
tadalafil drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | tadalafil | 46708-177 |
| Alembic Pharmaceuticals Inc | tadalafil | 62332-177 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
tadalafil drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Avkare | tadalafil | 42291-786 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICA
tadalafil drug variants containing SILICA
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | tadalafil | 50090-7390 |
| A-S Medication Solutions | tadalafil | 50090-7391 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SILICA
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
tadalafil drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6976 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
tadalafil drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
tadalafil drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | tadalafil | 33342-265 |
| Macleods Pharmaceuticals Limited | tadalafil | 33342-278 |
| A-S Medication Solutions | tadalafil | 50090-5724 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURETH SULFATE
tadalafil drug variants containing SODIUM LAURETH SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | tadalafil | 13668-581 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SODIUM LAURETH SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
tadalafil drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | tadalafil | 13668-581 |
| NorthStar RxLLC | tadalafil | 16714-074 |
| Accord Healthcare Inc | tadalafil | 16729-369 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
tadalafil drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| GLENMARK PHARMACEUTICALS INC USA | tadalafil | 68462-779 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
tadalafil drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Avkare | tadalafil | 42291-786 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
tadalafil drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Macleods Pharmaceuticals Limited | tadalafil | 33342-265 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOSTEARATE
tadalafil drug variants containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | tadalafil | 16729-369 |
| A-S Medication Solutions | tadalafil | 50090-6150 |
| Unit Dose Services | tadalafil | 50436-0370 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: SOYBEAN LECITHIN
tadalafil drug variants containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | tadalafil | 68788-8465 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
tadalafil drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | tadalafil | 0480-2309 |
| Teva Pharmaceuticals Inc | tadalafil | 0480-9277 |
| A-S Medication Solutions | tadalafil | 50090-5627 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
tadalafil drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| ANI Pharmaceuticals Inc | tadalafil | 70954-433 |
| ANI Pharmaceuticals Inc | tadalafil | 70954-627 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
tadalafil drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| Teva Pharmaceuticals Inc | tadalafil | 0480-9277 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
tadalafil drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| A-S Medication Solutions | tadalafil | 50090-7390 |
| A-S Medication Solutions | tadalafil | 50090-7391 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
tadalafil drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6970 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6971 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| Mylan Pharmaceuticals Inc | tadalafil | 0378-6976 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRICETIN
tadalafil drug variants containing TRICETIN
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | tadalafil | 13668-581 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing TRICETIN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
tadalafil drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
tadalafil drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
tadalafil drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| CMP Pharma Inc | tadalafil | 46287-045 |
| >Company | >Ingredient | >NDC |
tadalafil drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | tadalafil | 0002-4465 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3016 |
| Teva Pharmaceuticals USA Inc | tadalafil | 0093-3334 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
